Sutro Biopharma (STRO) Earnings Date, Estimates & Call Transcripts $3.63 -0.33 (-8.33%) (As of 10:47 AM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Sutro Biopharma Latest Earnings SummaryLatest Q2 2024 Earnings DateAug. 13EstimatedActual EPS (Aug. 13) -$0.59 Beat By $0.20 Consensus EPS (Aug. 13) -$0.79 Sutro Biopharma posted Q2 2024 earnings on August 13, 2024, reporting an EPS of -$0.59, which topped analysts' consensus estimates of -$0.79 by $0.20. Quarterly revenue was reported to be $25.71 million, below analyst estimates of $26.28 million. With a trailing EPS of -$1.83, Sutro Biopharma's earnings are expected to grow next year, from ($2.96) to ($2.90) per share. Get Sutro Biopharma Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sutro Biopharma and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataSTRO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.STRO Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Stansberry ResearchPost-Election Bitcoin WarningAccording to the man who has called nearly every bubble of the last 25 years, Bitcoin owners should get ready to pay back all the gains they've seen the last few months... Click here to see Dan's full warning (and his potential solution) Sutro Biopharma Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242-$0.95-$0.73-$0.84Q2 20242-$0.99-$0.09-$0.54Q3 20242-$0.85-$0.65-$0.75Q4 20242-$0.79-$0.69-$0.74FY 20248-$3.58-$2.16-$2.87Q1 20251-$0.90-$0.90-$0.90Q2 20251-$0.69-$0.69-$0.69Q3 20251-$0.70-$0.70-$0.70Q4 20251-$0.74-$0.74-$0.74FY 20254($3.03)($3.03)($3.03) Sutro Biopharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks8/13/2024Q2 2024-$0.79-$0.59+$0.20-$0.59$26.28M$25.71M5/13/2024Q1 2024-$0.92-$0.95 -$0.03-$0.95$11.57M$13.01M3/25/2024Q4 2023-$0.82$0.42+$1.24$0.32$12.16M$113.72M11/13/2023Q3 2023-$0.76-$0.81 -$0.05-$0.81$12.08M$16.92M8/10/2023Q2 2023-$0.73-$0.64+$0.09-$0.64$10.45M$10.41M5/15/2023Q1 2023-$0.83-$0.76+$0.07-$0.67$11.35M$12.67M Get the Latest News and Ratings for STRO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sutro Biopharma and its competitors with MarketBeat's FREE daily newsletter. 3/30/2023Q4 2022-$0.64-$0.61+$0.03-$0.61$11.50M$8.63M Sutro Biopharma Earnings - Frequently Asked Questions When did Sutro Biopharma announce their last quarterly earnings? Sutro Biopharma (NASDAQ:STRO) last announced its quarterly earning data on Tuesday, August 13, 2024. Learn more on STRO's earnings history. Did Sutro Biopharma beat their earnings estimates last quarter? In the previous quarter, Sutro Biopharma (NASDAQ:STRO) reported ($0.59) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.79) by $0.20. Learn more on analysts' earnings estimate vs. STRO's actual earnings. How much revenue does Sutro Biopharma generate each year? Sutro Biopharma (NASDAQ:STRO) has a recorded annual revenue of $169.36 million. How much profit does Sutro Biopharma generate each year? Sutro Biopharma (NASDAQ:STRO) has a recorded net income of -$106.79 million. STRO has generated -$1.83 earnings per share over the last four quarters. What is Sutro Biopharma's EPS forecast for next year? Sutro Biopharma's earnings are expected to grow from ($2.96) per share to ($2.90) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies GYRE Earnings Results PRAX Earnings Results KURA Earnings Results SAVA Earnings Results ANIP Earnings Results ARQT Earnings Results ARDX Earnings Results CALT Earnings Results BCYC Earnings Results APLT Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings ReportPulteGroup Earnings Signal Potential Entry Points for InvestorsTaiwan Semiconductor Soars on Earnings With More Room to Run Post-Election Bitcoin Warning (Ad)According to the man who has called nearly every bubble of the last 25 years, Bitcoin owners should get ready to pay back all the gains they've seen the last few months... Click here to see Dan's full warning (and his potential solution) This page (NASDAQ:STRO) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredIs Your 401(k) Safe? The Real Risk No One Sees ComingEvery day you wait, your savings are at greater risk. The government isn't slowing down, inflation isn't stopp...Golden Crest | SponsoredCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sutro Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sutro Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free STRO Stock Alerts